| Pan-GWAS of Streptococcus agalactiae highlights lineage-specific genes associated with virulence and niche adaptation A Gori, OB Harrison, E Mlia, Y Nishihara, JM Chan, J Msefula, M Mallewa, ... MBio 11 (3), 10.1128/mbio. 00728-20, 2020 | 60 | 2020 |
| SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021 J Mandolo, J Msefula, MYR Henrion, C Brown, B Moyo, A Samon, ... BMC medicine 19, 1-10, 2021 | 56 | 2021 |
| Impact and effectiveness of 13-valent pneumococcal conjugate vaccine on population incidence of vaccine and non-vaccine serotype invasive pneumococcal disease in Blantyre … N Bar-Zeev, TD Swarthout, DB Everett, M Alaerts, J Msefula, C Brown, ... The Lancet Global Health 9 (7), e989-e998, 2021 | 43 | 2021 |
| Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3+ 0 schedule, within the first year of life among children younger than 5 years in … TD Swarthout, MYR Henrion, D Thindwa, JE Meiring, M Mbewe, ... The Lancet Infectious Diseases 22 (12), 1737-1747, 2022 | 33 | 2022 |
| Evaluation of pneumococcal serotyping of nasopharyngeal-carriage isolates by latex agglutination, whole-genome sequencing (PneumoCaT), and DNA microarray in a high-pneumococcal … TD Swarthout, A Gori, N Bar-Zeev, AW Kamng’ona, TS Mwalukomo, ... Journal of clinical microbiology 59 (1), 10.1128/jcm. 02103-20, 2020 | 13 | 2020 |
| Pan-GWAS of Streptococcus agalactiae highlights lineage-specific genes associated with virulence and niche adaptation. mBio 11: e00728-20 A Gori, OB Harrison, E Mlia, Y Nishihara, JM Chan, J Msefula, M Mallewa, ... Article PubMed PubMed Central, 2020 | 12 | 2020 |
| Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation AS Wolf, E Mitsi, S Jones, SP Jochems, L Roalfe, D Thindwa, JE Meiring, ... Vaccine 40 (50), 7201-7210, 2022 | 8 | 2022 |
| The metabolic, virulence and antimicrobial resistance profiles of colonising Streptococcus pneumoniae shift after PCV13 introduction in urban Malawi U Obolski, TD Swarthout, A Kalizang’oma, TS Mwalukomo, JM Chan, ... Nature Communications 14 (1), 7477, 2023 | 5 | 2023 |
| Changing incidence of invasive pneumococcal disease in infants less than 90 days of age before and after introduction of the 13-valent pneumococcal conjugate vaccine in … M Koenraads, TD Swarthout, N Bar-Zeev, C Brown, J Msefula, B Denis, ... The Pediatric infectious disease journal 41 (9), 764-768, 2022 | 5 | 2022 |
| A pragmatic health centre-based evaluation comparing the effectiveness of a PCV13 schedule change from 3+ 0 to 2+ 1 in a high pneumococcal carriage and disease burden setting … TD Swarthout, A Ibarz-Pavon, G Kawalazira, G Sinjani, J Chirombo, ... BMJ open 11 (6), e050312, 2021 | 5 | 2021 |
| Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi A Kirolos, TD Swarthout, AA Mataya, F Bonomali, C Brown, J Msefula, ... BMC infectious diseases 23 (1), 56, 2023 | 4 | 2023 |
| The metabolic, virulence and antimicrobial resistance profiles of colonizing Streptococcus pneumoniae shift after pneumococcal vaccine introduction in urban Malawi A Gori, U Obolski, TD Swarthout, J Lourenço, CM Weight, J Cornick, ... medRxiv, 2021.07. 21.21260914, 2021 | 4 | 2021 |
| Complete genome sequence of Streptococcus pneumoniae strain BVJ1JL, a serotype 1 carriage isolate from Malawi M Betts, S Jarvis, A Jeffries, A Gori, C Chaguza, J Msefula, CM Weight, ... Microbiology resource announcements 10 (39), 10.1128/mra. 00715-21, 2021 | 3 | 2021 |
| Clonal Expansion of a Streptococcus pneumoniae Serotype 3 Capsule Variant Sequence Type 700 With Enhanced Vaccine Escape Potential After 13-Valent … A Kalizang'oma, TD Swarthout, TS Mwalukomo, A Kamng’ona, C Brown, ... The Journal of Infectious Diseases, jiae040, 2024 | 2 | 2024 |
| Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi D Thindwa, TS Mwalukomo, J Msefula, KC Jambo, C Brown, ... AIDS 36 (14), 2045-2055, 2022 | 2 | 2022 |
| Dynamics of SARS-CoV-2 exposure in Malawian blood donors: a retrospective seroprevalence analysis between January 2020 and February 2021 J Mandolo, J Msefula, MYR Henrion, C Brown, B Moyo, A Samon, ... medRxiv, 2021.08. 18.21262207, 2021 | 2 | 2021 |
| Evaluating methods for identifying and quantifying Streptococcus pneumoniae co-colonisation using next-generation sequencing data J Hackman, M Hibberd, T Swarthout, J Hinds, J Ashall, C Sheppard, ... Microbiology Spectrum, 2024 | | 2024 |
| Expansion of pneumococcal serotype 23F and 14 lineages with genotypic changes in capsule polysaccharide locus and virulence gene profiles post introduction of pneumococcal … R Cave, A Kalizang'oma, C Chaguza, TS Mwalukomo, A Kamng’ona, ... Microbial Genomics 10 (6), 001264, 2024 | | 2024 |
| Pediatric Phoenix Sepsis Score Validation Challenges in Low-Resource Settings and in the ED J Msefula, M Kumwenda, JCJ Calis JAMA, 2024 | | 2024 |
| The role of biomarkers in low-and-middle income countries in Africa J Msefula, M Havara, N Nandoe, G Mkandawire, M Witte TROPICAL MEDICINE & INTERNATIONAL HEALTH 28, 343-344, 2023 | | 2023 |
